Rajnish Wellness reported a significant turnaround in its standalone financial results for the quarter ended June 30, 2026, driven by a substantial rise in operational income and overall profitability. The company’s total income from operations surged to ₹3,101.15 lakh, a steep increase from ₹455.62 lakh in the corresponding period of FY25. This operational boost contributed to a net profit before tax of ₹3,109.18 lakh, compared to ₹467.29 lakh in Q1FY25.

Financial Performance Overview

The Board of Directors approved the unaudited standalone financial results on August 13, 2026. The statutory auditors carried out a limited review of the results. While the headline profit figures show robust growth, a closer look at the components reveals that the majority of the profit was derived from non-operational or exceptional items rather than core trading activities.

What the Numbers Show

The divergence between the pre-exceptional and post-exceptional profit figures is the most critical aspect of this filing. While the company reported a total pre-exceptional profit of ₹3,109.18 lakh, the profit after adjusting for exceptional and/or extraordinary items stood at just ₹12.30 lakh. This indicates that approximately ₹3,096.88 lakh of the reported profit was attributable to non-recurring or exceptional factors. Consequently, the core operational profitability, represented by the post-exceptional figure, actually declined from ₹29.07 lakh in Q1FY26 to ₹12.30 lakh in Q1FY27. Investors should note that the headline earnings per share of ₹0.0012 reflects this adjusted position, down from ₹0.0028 in the prior year.

Balance Sheet and Capital Structure

The company’s equity share capital increased to ₹10,153.47 lakh in Q1FY27, up from ₹7,684.75 lakh in Q1FY26, suggesting potential capital raising or bonus issuance activities during the year. Reserves, excluding revaluation reserves, stood at ₹102.74 lakh, a decrease from ₹731.47 lakh in the same quarter last year, likely reflecting the absorption of losses or dividends paid during the intervening periods. The full format of the quarterly financial results is available on the BSE website and the company’s official portal.

Rajnish Wellness Limited reported a net loss of ₹62.87 crore for the financial year ended March 31, 2026, compared to a net profit of ₹1.73 crore in the previous year. Revenue from operations for the year surged to ₹1,417.52 crore from ₹485.61 crore in the previous year. The board approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026. Subsequently, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company submitted newspaper clippings of its audited financial results to BSE Limited on June 01, 2026. The results were published in Active Times (English edition) and Mumbai Lakshadeep (Marathi edition).

For the quarter ended March 31, 2026, the company reported a net loss of ₹4.69 crore on revenue from operations of ₹101.94 crore. The statutory auditor, Motilal & Associates LLP, issued an unmodified opinion on the financial results. However, the auditor drew attention to a material write-off of sundry debtors amounting to ₹9.70 crore during the year, as the management assessed these balances as irrecoverable.

Total income for FY26 stood at ₹1,425.76 crore, while total expenses increased to ₹1,509.90 crore. The company's paid-up equity share capital was ₹101.53 crore as of March 31, 2026. Basic earnings per share for the year were (₹0.06), compared to ₹0.00 in the previous year. The board of directors did not recommend any dividend for the financial year 2025-26. The company operates in a single segment, Pharmaceuticals & FMCG, and there were no investor complaints received during the quarter and year ended March 31, 2026.

Financial Highlights for FY26

The table below presents the key financial metrics for Rajnish Wellness for the year and quarter ended March 31, 2026, compared to the previous year.

Regulatory Compliance

The financial results are prepared in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The trading window for dealing in the company's securities, which closed on April 01, 2026, will reopen 48 hours after the declaration of the audited financial results on the stock exchange. The newspaper clipping submission was signed by Managing Director Rajnishkumar Singh (DIN: 07192704) on June 01, 2026.